Company profile for Allay Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians. We believe an era of stalled innovation for pain management is over. We see the future of our field including a dramatically expanded toolkit with safer, longer-lasting and more tailored solutions that reduce the burden of recovery. Crucially, this includes solutions that...
Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians. We believe an era of stalled innovation for pain management is over. We see the future of our field including a dramatically expanded toolkit with safer, longer-lasting and more tailored solutions that reduce the burden of recovery. Crucially, this includes solutions that address the drawbacks of opioids to reduce related issues of addiction, hospitalization, lengthy rehabilitation and overall costs to the healthcare system.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4040 Campbell Avenue Suite 110 Menlo Park, CA 94025 U.S.
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250605811033/en/Allay-Therapeutics-Announces-%2457.5M-Series-D-Financing-and-Venture-Debt-Line-to-Advance-ATX101-and-its-Ultra-Sustained-Pain-Platform-for-Post-Surgical-Pain-Management

BUSINESSWIRE
05 Jun 2025

https://www.businesswire.com/news/home/20250218367829/en

BUSINESSWIRE
18 Feb 2025

https://www.businesswire.com/news/home/20241024814344/en

BUSINESSWIRE
24 Oct 2024

https://www.businesswire.com/news/home/20240612724108/en

BUSINESSWIRE
12 Jun 2024
Brandon Capital raises $180M for Australia, New Zealand biotechs
Brandon Capital raises $180M for Australia, New Zealand biotechs

04 Jun 2024

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/brandon-capital-raises-180m-fund-support-australia-new-zealand-biotechs

Annalee Armstrong FIERCE BIOTECH
04 Jun 2024

https://www.businesswire.com/news/home/20240411932048/en

BUSINESSWIRE
11 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty